In general, the present study showed that CLCA4 may inhibit HCC cell migration and invasion by suppressing EMT via PI3K/AKT pathway, and could act as a potential prognostic biomarker for HCC patients. The gene discussed is AKT1; the disease is hepatocellular carcinoma.